抑制白介素36受体信号可减轻慢性肠道炎症小鼠的纤维化
研究检测了92例克罗恩病、48例溃疡性结肠炎和26例对照者的肠道组织,发现纤维狭窄型克罗恩病组织中IL36A升高且与活化成纤维细胞相关。小鼠实验显示IL36R激活成纤维细胞促进纤维化基因表达,而敲除IL1RL2或注射抗IL36R抗体可减轻慢性结肠炎和纤维化。
要点
- 纤维狭窄型克罗恩病患者肠组织中IL36A水平显著升高,与表达α平滑肌肌动蛋白的活化成纤维细胞增多相关。
- IL36R激活可诱导人和小鼠成纤维细胞表达调控纤维化与组织重塑的基因及VI型胶原。
- Il1rl2-/-小鼠或注射抗IL36R抗体的小鼠在DSS或TNBS诱导后结肠炎和纤维化较轻。
主要发现
- 克罗恩病或溃疡性结肠炎患者的黏膜和黏膜下组织中胶原(包括VI型胶原)水平高于对照者。
- 纤维狭窄型克罗恩病患者组织中IL36A水平显著升高,且与表达α平滑肌肌动蛋白的活化成纤维细胞数量增多相关。
- IL36R激活使小鼠和人成纤维细胞表达调控纤维化和组织重塑的基因以及VI型胶原。
- Il1rl2-/-小鼠和注射抗IL36R抗体的小鼠在DSS或TNBS给药后结肠炎和纤维化较轻,但Il1rl2-/-小鼠的骨髓细胞不能阻止结肠炎和纤维化的诱导。
- 注射抗IL36R抗体可显著减轻慢性肠道炎症小鼠已建立的纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Intestinal fibrosis is a long-term complication in inflammatory bowel diseases (IBD) that frequently results in functional damage, bowel obstruction, and surgery. Interleukin (IL) 36 is a group of cytokines in the IL1 family with inflammatory effects. We studied the expression of IL36 and its receptor, interleukin 1 receptor like 2 (IL1RL2 or IL36R) in the development of intestinal fibrosis in human tissues and mice. METHODS: We obtained intestinal tissues from 92 patients with Crohn's disease (CD), 48 patients with ulcerative colitis, and 26 patients without inflammatory bowel diseases (control individuals). Tissues were analyzed by histology to detect fibrosis and by immunohistochemistry to determine the distribution of fibroblasts and levels of IL36R ligands. Human and mouse fibroblasts were incubated with IL36 or control medium, and transcriptome-wide RNA sequences were analyzed. Mice were given neutralizing antibodies against IL36R, and we studied intestinal tissues from Il1rl2-/- mice; colitis and fibrosis were induced in mice by repetitive administration of DSS or TNBS. Bone marrow cells were transplanted from Il1rl2-/- to irradiated wild-type mice and intestinal tissues were analyzed. Antibodies against IL36R were applied to mice with established chronic colitis and fibrosis and intestinal tissues were studied. RESULTS: Mucosal and submucosal tissue from patients with CD or ulcerative colitis had higher levels of collagens, including type VI collagen, compared with tissue from control individuals. In tissues from patients with fibrostenotic CD, significantly higher levels of IL36A were noted, which correlated with high numbers of activated fibroblasts that expressed α-smooth muscle actin. IL36R activation of mouse and human fibroblasts resulted in expression of genes that regulate fibrosis and tissue remodeling, as well as expression of collagen type VI. Il1rl2-/- mice and mice given injections of an antibody against IL36R developed less severe colitis and fibrosis after administration of DSS or TNBS, but bone marrow cells from Il1rl2-/- mice did not prevent induction of colitis and fibrosis. Injection of antibodies against IL36R significantly reduced established fibrosis in mice with chronic intestinal inflammation. CONCLUSION: We found higher levels of IL36A in fibrotic intestinal tissues from patients with IBD compared with control individuals. IL36 induced expression of genes that regulate fibrogenesis in fibroblasts. Inhibition or knockout of the IL36R gene in mice reduces chronic colitis and intestinal fibrosis. Agents designed to block IL36R signaling could be developed for prevention and treatment of intestinal fibrosis in patients with IBD.
引用
- Scheibe K, Kersten C, Schmied A, et al. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. Gastroenterology. 2018. PMID: 30452921. doi:10.1053/j.gastro.2018.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。